Area of research
Epidemiology · Surgery
Research interest
Research focused on Pediatrics and Coronavirus disease 2019 (COVID-19), with related work in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Population, Vaccination. Notable publications include 'Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2', 'Risk Factors for Severe COVID-19 in Children', and 'Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016'.
Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022–2024
Molecular mimicry in multisystem inflammatory syndrome in children
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in Children
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs*
1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022
Variation in Early Anakinra Use and <scp>Short‐Term</scp> Outcomes in Multisystem Inflammatory Syndrome in Children
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States
Multisystem Inflammatory Syndrome in Children During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta and Omicron Variant Circulation—United States, July 2021–January 2022
BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5–18 Years—United States, July 2021 – April 2022
Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents
Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
Risk Factors for Severe COVID-19 in Children
Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021
Influenza Antiviral Treatment and Length of Stay
Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016
Outcomes of Immunocompromised Adults Hospitalized With Laboratory-confirmed Influenza in the United States, 2011–2015
Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011–2015
Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015